Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-31 @ 6:25 AM
Study NCT ID:
NCT03020004
Status:
COMPLETED
Last Update Posted:
2018-07-26
First Post:
2017-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II
Sponsor:
Ascletis Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
None
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-05
First Submit QC Date:
None
Study First Post Date:
2017-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-09
Results First Submit QC Date:
None
Results First Post Date:
2018-02-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-27
Last Update Post Date:
2018-07-26
Last Update Post Date Type:
ACTUAL